CHINA PHARMA HOLDINGS, INC. Interest Expense
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Interest Expense of $9.31 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. interest expense for the quarter ending 2026-06-30 was $9.31K, a 37.44% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense for the quarter ending 2026-03-31 was $9.09K, a 33.86% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense for the quarter ending 2025-12-31 was $6.88K, a 1.13% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense for the quarter ending 2025-09-30 was $6.80K, a 0.66% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense for fiscal 2025 was $27.27K, a 0.30% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. interest expense for fiscal 2024 was $27.35K, a 10.53% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. interest expense for fiscal 2023 was $30.57K, a 92.97% decline from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. interest expense for fiscal 2022 was $434.62K, a 19.81% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.31K 10-Q · filed 2026-08-14 | $18.39K 10-Q · filed 2026-08-14 | $25.27K derived: sum of 3 quarters · filed 2026-08-14 | $32.07K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $9.09K 10-Q · filed 2026-05-15 | $15.96K derived: sum of 2 quarters · filed 2026-05-15 | $22.76K derived: sum of 3 quarters · filed 2026-05-15 | $29.53K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $6.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $13.68K derived: sum of 2 quarters · filed 2026-04-01 | $20.45K derived: sum of 3 quarters · filed 2026-08-14 | $27.27K 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | $6.80K 10-Q · filed 2025-11-12 | $13.57K derived: sum of 2 quarters · filed 2026-08-14 | $20.39K 10-Q · filed 2025-11-12 | $27.16K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $6.77K 10-Q · filed 2026-08-14 | $6.78K 10-Q · filed 2025-08-14 | $13.56K 10-Q · filed 2026-08-14 | $20.36K derived: sum of 3 quarters · filed 2026-08-14 | $27.20K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $6.79K 10-Q · filed 2026-05-15 | $13.59K derived: sum of 2 quarters · filed 2026-05-15 | $20.43K derived: sum of 3 quarters · filed 2026-05-15 | $27.28K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $6.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $13.64K derived: sum of 2 quarters · filed 2026-04-01 | $20.50K derived: sum of 3 quarters · filed 2026-04-01 | $27.35K 10-K · filed 2026-04-01 | ||||
| 2024-09-30 | $6.84K 10-Q · filed 2025-11-12 | $13.70K derived: sum of 2 quarters · filed 2025-11-12 | $20.55K 10-Q · filed 2025-11-12 | $30.30K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $6.85K 10-Q · filed 2025-08-14 | $13.71K 10-Q · filed 2025-08-14 | $23.45K derived: sum of 3 quarters · filed 2025-08-14 | $30.39K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $6.86K 10-Q · filed 2025-05-14 | $16.60K derived: sum of 2 quarters · filed 2025-05-14 | $23.54K derived: sum of 3 quarters · filed 2025-05-14 | $161.21K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $9.74K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $16.69K derived: sum of 2 quarters · filed 2025-03-31 | $154.35K derived: sum of 3 quarters · filed 2025-03-31 | $30.57K 10-K · filed 2025-03-31 | $333.60K 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $6.94K 10-Q · filed 2024-11-13 | $66.24K 10-Q · filed 2023-11-13 | $144.60K derived: sum of 2 quarters · filed 2024-11-13 | $20.83K 10-Q · filed 2024-11-13 | $283.35K 10-Q · filed 2023-11-13 | $320.23K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $137.66K 10-Q · filed 2023-08-14 | $217.11K 10-Q · filed 2023-08-14 | $313.28K derived: sum of 3 quarters · filed 2024-04-01 | $417.26K derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2023-03-31 | $79.44K 10-Q · filed 2023-05-12 | $175.62K derived: sum of 2 quarters · filed 2024-04-01 | $279.60K derived: sum of 3 quarters · filed 2024-04-01 | $389.64K derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-12-31 | $96.17K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $200.15K derived: sum of 2 quarters · filed 2024-04-01 | $310.19K derived: sum of 3 quarters · filed 2024-04-01 | $434.62K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $103.98K 10-Q · filed 2023-11-13 | $214.02K derived: sum of 2 quarters · filed 2023-11-13 | $338.44K 10-Q · filed 2023-11-13 | $671.88K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $110.04K 10-Q · filed 2023-08-14 | $234.47K 10-Q · filed 2023-08-14 | $567.91K derived: sum of 3 quarters · filed 2023-08-14 | $632.81K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $124.43K 10-Q · filed 2023-05-12 | $457.87K derived: sum of 2 quarters · filed 2023-05-12 | $522.77K derived: sum of 3 quarters · filed 2023-05-12 | $595.16K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $333.44K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $398.34K derived: sum of 2 quarters · filed 2023-03-30 | $470.74K derived: sum of 3 quarters · filed 2023-03-30 | $542.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $64.90K 10-Q · filed 2022-11-14 | $137.29K derived: sum of 2 quarters · filed 2022-11-14 | $208.56K 10-Q · filed 2022-11-14 | $316.50K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $72.39K 10-Q · filed 2022-08-11 | $143.66K 10-Q · filed 2022-08-11 | $251.60K derived: sum of 3 quarters · filed 2022-08-11 | $312.67K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $71.27K 10-Q · filed 2022-05-12 | $179.21K derived: sum of 2 quarters · filed 2022-05-12 | $240.28K derived: sum of 3 quarters · filed 2022-05-12 | $303.42K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $107.94K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $169.01K derived: sum of 2 quarters · filed 2022-03-30 | $232.16K derived: sum of 3 quarters · filed 2022-03-30 | $294.16K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $61.07K 10-Q · filed 2021-11-12 | $124.21K derived: sum of 2 quarters · filed 2021-11-12 | $186.21K 10-Q · filed 2021-11-12 | $256.31K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $63.14K 10-Q · filed 2021-08-13 | $125.15K 10-Q · filed 2021-08-13 | $195.24K derived: sum of 3 quarters · filed 2021-08-13 | $262.83K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $62.00K 10-Q · filed 2021-05-14 | $132.10K derived: sum of 2 quarters · filed 2021-05-14 | $199.69K derived: sum of 3 quarters · filed 2021-05-14 | $296.94K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $70.09K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $137.68K derived: sum of 2 quarters · filed 2021-03-26 | $234.94K derived: sum of 3 quarters · filed 2021-03-26 | $321.72K 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | $67.59K 10-Q · filed 2020-11-13 | $164.84K derived: sum of 2 quarters · filed 2020-11-13 | $251.62K 10-Q · filed 2020-11-13 | $341.52K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $97.25K 10-Q · filed 2020-08-13 | $184.03K 10-Q · filed 2020-08-13 | $273.93K derived: sum of 3 quarters · filed 2020-08-13 | $375.61K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $86.78K 10-Q · filed 2020-05-14 | $176.67K derived: sum of 2 quarters · filed 2020-05-14 | $278.36K derived: sum of 3 quarters · filed 2020-05-14 | $408.94K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $89.89K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $191.58K derived: sum of 2 quarters · filed 2020-03-30 | $322.16K derived: sum of 3 quarters · filed 2020-03-30 | $451.26K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $101.68K 10-Q · filed 2019-11-14 | $232.26K derived: sum of 2 quarters · filed 2019-11-14 | $361.37K 10-Q · filed 2019-11-14 | $488.71K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $130.58K 10-Q · filed 2019-08-14 | $259.68K 10-Q · filed 2019-08-14 | $387.03K derived: sum of 3 quarters · filed 2019-08-14 | $517.85K derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $129.10K 10-Q · filed 2019-05-14 | $256.45K derived: sum of 2 quarters · filed 2019-05-14 | $387.27K derived: sum of 3 quarters · filed 2019-05-14 | $529.47K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $127.35K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $258.17K derived: sum of 2 quarters · filed 2019-03-28 | $400.37K derived: sum of 3 quarters · filed 2019-03-28 | $539.33K 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $130.82K 10-Q · filed 2018-11-14 | $273.02K derived: sum of 2 quarters · filed 2018-11-14 | $411.99K 10-Q · filed 2018-11-14 | $561.61K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $142.21K 10-Q · filed 2018-08-14 | $281.17K 10-Q · filed 2018-08-14 | $430.79K derived: sum of 3 quarters · filed 2018-08-14 | $644.53K derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $138.96K 10-Q · filed 2018-05-14 | -$138.96K 10-Q · filed 2017-05-11 | $288.59K derived: sum of 2 quarters · filed 2018-05-14 | $502.33K derived: sum of 3 quarters · filed 2018-05-14 | $746.21K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $149.63K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $363.37K derived: sum of 2 quarters · filed 2018-04-02 | $607.25K derived: sum of 3 quarters · filed 2018-04-02 | $849.56K 10-K · filed 2018-04-02 | -$849.56K 10-K · filed 2017-03-31 | |||
| 2016-09-30 | $213.74K 10-Q · filed 2017-11-14 | $457.62K derived: sum of 2 quarters · filed 2017-11-14 | $699.93K 10-Q · filed 2017-11-14 | -$1.87M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $243.88K 10-Q · filed 2017-08-14 | $486.19K 10-Q · filed 2017-08-14 | -$2.08M derived: sum of 3 quarters · filed 2017-08-14 | -$1.80M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$242.31K 10-Q · filed 2017-05-11 | $242.31K 10-Q · filed 2016-05-16 | -$2.32M derived: sum of 2 quarters · filed 2017-05-11 | -$2.04M derived: sum of 3 quarters · filed 2017-05-11 | -$1.72M derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$1.80M derived: sum of 2 quarters · filed 2017-03-31 | -$1.48M derived: sum of 3 quarters · filed 2017-03-31 | -$1.17M 10-K · filed 2017-03-31 | $1.17M 10-K · filed 2016-03-30 | |||
| 2015-09-30 | $279.11K 10-Q · filed 2016-11-14 | -$279.11K 10-Q · filed 2015-11-16 | $601.53K derived: sum of 2 quarters · filed 2016-11-14 | $915.31K 10-Q · filed 2016-11-14 | -$915.31K 10-Q · filed 2015-11-16 | $2.20M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $322.42K 10-Q · filed 2016-08-11 | -$322.42K 10-Q · filed 2015-08-14 | $636.20K 10-Q · filed 2016-08-11 | -$636.20K 10-Q · filed 2015-08-14 | $1.92M derived: sum of 3 quarters · filed 2016-08-11 | $1.59M derived: sum of 4 quarters · filed 2016-08-11 | ||
| 2015-03-31 | $313.77K 10-Q · filed 2016-05-16 | -$313.77K 10-Q · filed 2015-05-11 | $1.59M derived: sum of 2 quarters · filed 2016-05-16 | $1.27M derived: sum of 3 quarters · filed 2016-05-16 | $1.16M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $955.61K derived: sum of 2 quarters · filed 2016-03-30 | $842.25K derived: sum of 3 quarters · filed 2016-03-30 | $785.80K 10-K · filed 2016-03-30 | -$785.80K 10-K · filed 2015-03-30 | |||
| 2014-09-30 | -$325.24K 10-Q · filed 2015-12-28 | -$438.61K derived: sum of 2 quarters · filed 2015-12-28 | -$495.05K 10-Q · filed 2015-12-28 | -$580.02K derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2014-06-30 | -$113.36K 10-Q · filed 2015-12-28 | -$169.81K 10-Q · filed 2015-12-28 | -$254.77K derived: sum of 3 quarters · filed 2015-12-28 | -$344.01K derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2014-03-31 | -$56.45K 10-Q · filed 2015-12-28 | $56.45K 10-Q · filed 2014-05-15 | -$141.41K derived: sum of 2 quarters · filed 2015-12-28 | -$230.65K derived: sum of 3 quarters · filed 2015-12-28 | -$322.70K derived: sum of 4 quarters · filed 2015-12-28 | |||
| 2013-12-31 | -$84.96K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | -$174.20K derived: sum of 2 quarters · filed 2015-12-28 | -$266.25K derived: sum of 3 quarters · filed 2015-12-28 | -$348.70K 10-K · filed 2015-12-28 | ||||
| 2013-09-30 | -$89.24K 10-Q · filed 2014-11-14 | -$181.29K derived: sum of 2 quarters · filed 2014-11-14 | -$263.73K 10-Q · filed 2014-11-14 | -$171.70K derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | -$92.05K 10-Q · filed 2014-08-14 | -$174.49K 10-Q · filed 2014-08-14 | -$82.46K derived: sum of 3 quarters · filed 2014-08-14 | -$161.97K derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $82.44K 10-Q · filed 2014-05-15 | -$82.44K 10-Q · filed 2013-05-14 | $9.59K derived: sum of 2 quarters · filed 2014-05-15 | -$69.92K derived: sum of 3 quarters · filed 2014-05-15 | -$148.39K derived: sum of 4 quarters · filed 2014-05-15 | |||
| 2012-12-31 | -$72.86K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$152.37K derived: sum of 2 quarters · filed 2014-03-20 | -$230.84K derived: sum of 3 quarters · filed 2014-03-20 | -$308.38K 10-K · filed 2014-03-20 | ||||
| 2012-09-30 | -$79.51K 10-Q · filed 2013-11-14 | -$157.98K derived: sum of 2 quarters · filed 2013-11-14 | -$235.52K 10-Q · filed 2013-11-14 | -$305.84K derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | -$78.47K 10-Q · filed 2013-08-14 | -$156.01K 10-Q · filed 2013-08-14 | -$226.33K derived: sum of 3 quarters · filed 2013-08-14 | -$288.77K derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | -$77.54K 10-Q · filed 2013-05-14 | -$147.86K derived: sum of 2 quarters · filed 2013-05-14 | -$210.30K derived: sum of 3 quarters · filed 2013-05-14 | -$271.52K derived: sum of 4 quarters · filed 2013-05-14 | ||||
| 2011-12-31 | -$70.32K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | -$132.76K derived: sum of 2 quarters · filed 2013-03-14 | -$193.98K derived: sum of 3 quarters · filed 2013-03-14 | -$255.20K 10-K · filed 2013-03-14 | ||||
| 2011-09-30 | -$62.44K 10-Q · filed 2012-11-14 | -$123.66K derived: sum of 2 quarters · filed 2012-11-14 | -$184.87K 10-Q · filed 2012-11-14 | -$213.34K derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | -$61.22K 10-Q · filed 2012-08-14 | -$122.44K 10-Q · filed 2012-08-14 | -$150.91K derived: sum of 3 quarters · filed 2012-08-14 | -$188.57K derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | -$61.21K 10-Q · filed 2012-05-14 | -$89.68K derived: sum of 2 quarters · filed 2012-05-14 | -$127.35K derived: sum of 3 quarters · filed 2012-05-14 | -$178.98K derived: sum of 4 quarters · filed 2012-05-14 | ||||
| 2010-12-31 | -$28.47K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | -$66.14K derived: sum of 2 quarters · filed 2012-03-14 | -$117.77K derived: sum of 3 quarters · filed 2012-03-14 | -$168.26K 10-K · filed 2012-03-14 | ||||
| 2010-09-30 | -$37.67K 10-Q/A · filed 2012-03-06 | -$89.30K derived: sum of 2 quarters · filed 2012-03-06 | -$139.79K 10-Q/A · filed 2012-03-06 | |||||
| 2010-06-30 | -$51.63K 10-Q/A · filed 2011-09-06 | -$102.12K 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |